Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2020

01-04-2020 | Breast Cancer | Abstracts

UK Interdisciplinary Breast Cancer Symposium 2020

Published in: Breast Cancer Research and Treatment | Issue 2/2020

Login to get access

Excerpt

1Centre for Cancer Prevention, Queen Mary University of London, London, United Kingdom. 2The University of Newcastle, Newcastle, Australia. 3Institute of Cancer Research, Ralph Lauren Centre, London, United Kingdom. 4North Bristol NHS Trust, Bristol, United Kingdom. 5Cardiff University, Cardiff, United Kingdom. 6German Breast Group, Frankfurt, Germany. 7Istituto Europeo di Oncologia, Milan, Italy. 8Manchester University, Manchester, United Kingdom …
Footnotes
1
PRECISION is sponsored by a Cancer Research UK Grand Challenge Award, which is also funded by the Dutch Cancer Society.
 
Metadata
Title
UK Interdisciplinary Breast Cancer Symposium 2020
Publication date
01-04-2020
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2020
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05514-3

Other articles of this Issue 2/2020

Breast Cancer Research and Treatment 2/2020 Go to the issue

Epidemiology

Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence

Epidemiology

Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women

Preclinical Study

Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity

Clinical Trial

Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial

Preclinical study

GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models

Preclinical study

Three-dimensional microanatomy of human nipple visualized by X-ray dark-field computed tomography
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits